Recently from our experts

Loading search

What might the next few years hold for Canadian pharmaceutical patent law?

An appeal to the Supreme Court of Canada on patent utility, a NAFTA investor-state dispute also on utility, and CETA provisions changing the nature of Canadian patent litigation, appeal rights and patent term extension, all weigh on the path ahead for Canada’s patent law, particularly as it applies...

Process patents and the partial outsourcing of individual procedural steps into patent-free foreign countries – opportunity or risk? A view from practice

In the case of cross-border situations, the question arises as to whether a patent-infringing act of use can be assumed if, in the case of a process patent, only a part of the procedural steps are carried out in the domestic patent-protected country, and other procedural steps are transferred to a...